MedTrace Logo

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

NCT06982469 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-06-19

No results posted yet for this study

Summary

The goal of this observational study is to learn about the long-term effects of HDR Brachytherapy in men with isolated local relapses after radical prostatectomy. The main question it aims to answer is:

Does HDR Brachytherapy increase control rates and decreases complications compared with conventional External Irradiation?

Participants will be asked to receive HDR brachytherapy as part of their regular medical care for isolated local relapses after radical prostatectomy

Conditions

  • Prostate Cancer
  • Prostatectomy
  • Local Recurrence of Malignant Tumor of Prostate
  • Radiotherapy; Complications
  • Brachytherapy

Interventions

RADIATION

Brachytherapy

HDR brachytherapy

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Rafael Martínez-Monge, M.D. · Clinica Universidad de Navarra Cancer Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2026-05-01
Completion
2030-05-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06982469 on ClinicalTrials.gov